Article
Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction: Detailed Phenotypes, Prognosis, and Response to Spironolactone.
JACC. Heart failure - 1 Mar 2020
Cohen Jordana B, Schrauben Sarah J, Zhao Lei, Basso Michael D, Cvijic Mary Ellen, Li Zhuyin, Yarde Melissa, Wang Zhaoqing, Bhattacharya Priyanka T, Chirinos Diana A, Prenner Stuart, Zamani Payman, Seiffert Dietmar A, Car Bruce D, Gordon David A, Margulies Kenneth, Cappola Thomas, Chirinos Julio A
Abstract excerpt
OBJECTIVES: This study sought to assess if clinical phenogroups differ in comprehensive biomarker profiles, cardiac and arterial structure/function, and responses to spironolactone therapy. BACKGROUND: Previous studies identified distinct subgroups (phenogroups) of patients with heart failure with preserved ejection fraction (HFpEF). METHODS: Among TOPCAT (Treatment of Preserved Cardiac Function Heart Failure...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
